These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 24100713)

  • 1. Infection duration and inflammatory imbalance are associated with atherosclerotic risk in HIV-infected never-smokers independent of antiretroviral therapy.
    Desvarieux M; Boccara F; Meynard JL; Bastard JP; Mallat Z; Charbit B; Demmer RT; Haddour N; Fellahi S; Tedgui A; Cohen A; Capeau J; Boyd A; Girard PM
    AIDS; 2013 Oct; 27(16):2603-14. PubMed ID: 24100713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of residual plasma viremia and intima-media thickness in antiretroviral-treated patients with controlled human immunodeficiency virus infection.
    Boyd A; Meynard JL; Morand-Joubert L; Michon A; Boccara F; Bastard JP; Samri A; Haddour N; Mallat Z; Capeau J; Desvarieux M; Girard PM;
    PLoS One; 2014; 9(11):e113876. PubMed ID: 25415323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.
    Ross AC; Rizk N; O'Riordan MA; Dogra V; El-Bejjani D; Storer N; Harrill D; Tungsiripat M; Adell J; McComsey GA
    Clin Infect Dis; 2009 Oct; 49(7):1119-27. PubMed ID: 19712036
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D insufficiency and subclinical atherosclerosis in non-diabetic males living with HIV.
    Portilla J; Moreno-Pérez O; Serna-Candel C; Escoín C; Alfayate R; Reus S; Merino E; Boix V; Giner L; Sánchez-Payá J; Picó A
    J Int AIDS Soc; 2014; 17(1):18945. PubMed ID: 24836607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children.
    McComsey GA; O'Riordan M; Hazen SL; El-Bejjani D; Bhatt S; Brennan ML; Storer N; Adell J; Nakamoto DA; Dogra V
    AIDS; 2007 May; 21(8):921-7. PubMed ID: 17457085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection.
    Bellinati PQ; Alfieri DF; Flauzino T; Junior PFG; Rossi DJ; Breganó JW; Simão ANC; de Almeida ERD; Lozovoy MAB; Reiche EMV
    Curr HIV Res; 2020; 18(4):292-306. PubMed ID: 32516102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipids, biomarkers, and subclinical atherosclerosis in treatment-naive HIV patients starting or not starting antiretroviral therapy: Comparison with a healthy control group in a 2-year prospective study.
    Di Yacovo S; Saumoy M; Sánchez-Quesada JL; Navarro A; Sviridov D; Javaloyas M; Vila R; Vernet A; Low H; Peñafiel J; García B; Ordoñez-Llanos J; Podzamczer D
    PLoS One; 2020; 15(8):e0237739. PubMed ID: 32817629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum Tryptophan-Derived Quinolinate and Indole-3-Acetate Are Associated With Carotid Intima-Media Thickness and its Evolution in HIV-Infected Treated Adults.
    Boyd A; Boccara F; Meynard JL; Ichou F; Bastard JP; Fellahi S; Samri A; Sauce D; Haddour N; Autran B; Cohen A; Girard PM; Capeau J;
    Open Forum Infect Dis; 2019 Dec; 6(12):ofz516. PubMed ID: 31890722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective, randomized clinical trial of antiretroviral therapies on carotid wall thickness.
    Stein JH; Ribaudo HJ; Hodis HN; Brown TT; Tran TT; Yan M; Brodell EL; Kelesidis T; McComsey GA; Dube MP; Murphy RL; Currier JS
    AIDS; 2015 Sep; 29(14):1775-83. PubMed ID: 26372383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelial activation and cardiometabolic profiles of treated and never-treated HIV infected Africans.
    Fourie CM; Schutte AE; Smith W; Kruger A; van Rooyen JM
    Atherosclerosis; 2015 May; 240(1):154-60. PubMed ID: 25795556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atherosclerosis is associated with multiple pathogenic mechanisms in HIV-infected antiretroviral-naive or treated individuals.
    Piconi S; Parisotto S; Rizzardini G; Passerini S; Meraviglia P; Schiavini M; Niero F; Biasin M; Bonfanti P; Ricci ED; Trabattoni D; Clerici M
    AIDS; 2013 Jan; 27(3):381-9. PubMed ID: 23079800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of Viral Persistence and Atherosclerosis in Adults With Treated HIV Infection.
    McLaughlin MM; Ma Y; Scherzer R; Rahalkar S; Martin JN; Mills C; Milush J; Deeks SG; Hsue PY
    JAMA Netw Open; 2020 Oct; 3(10):e2018099. PubMed ID: 33119103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D insufficiency is associated with subclinical atherosclerosis in HIV-1-infected patients on combination antiretroviral therapy.
    Calza L; Borderi M; Granozzi B; Malosso P; Pancaldi L; Bon I; Re MC
    HIV Res Clin Pract; 2019 Dec; 20(6):131-139. PubMed ID: 32065065
    [No Abstract]   [Full Text] [Related]  

  • 14. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arterial stiffness and carotid intima-media thickness in HIV infected patients.
    Papita A; Albu A; Fodor D; Itu C; Cârstina D
    Med Ultrason; 2011 Jun; 13(2):127-34. PubMed ID: 21655539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased carotid intima-media thickness in HIV patients is associated with increased cytomegalovirus-specific T-cell responses.
    Hsue PY; Hunt PW; Sinclair E; Bredt B; Franklin A; Killian M; Hoh R; Martin JN; McCune JM; Waters DD; Deeks SG
    AIDS; 2006 Nov; 20(18):2275-83. PubMed ID: 17117013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the atherosclerotic process accentuated under conditions of HIV infection, antiretroviral therapy, and protease inhibitor exposure? Meta-analysis of the markers of arterial structure and function.
    Sun D; Wu Y; Yuan Y; Wang Y; Liu W; Yang J
    Atherosclerosis; 2015 Sep; 242(1):109-16. PubMed ID: 26188532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased carotid intima-media thickness is not associated with T-cell activation nor with cytomegalovirus in HIV-infected never-smoker patients.
    Goulenok T; Boyd A; Larsen M; Fastenackels S; Boccara F; Meynard JL; Hadour N; Samri A; Desvarieux M; Autran B; Appay V; Girard PM; Sauce D;
    AIDS; 2015 Jan; 29(3):287-93. PubMed ID: 25686677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression of carotid intima-media thickness and coronary artery calcium over 6 years in an HIV-infected cohort.
    Volpe GE; Tang AM; Polak JF; Mangili A; Skinner SC; Wanke CA
    J Acquir Immune Defic Syndr; 2013 Sep; 64(1):51-7. PubMed ID: 23945252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of atherosclerosis as assessed by carotid intima-media thickness in patients with HIV infection.
    Hsue PY; Lo JC; Franklin A; Bolger AF; Martin JN; Deeks SG; Waters DD
    Circulation; 2004 Apr; 109(13):1603-8. PubMed ID: 15023877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.